 D47 |
|
Other neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue  |
| |
| D47.0 |
 |
Mast cell neoplasms of uncertain behavior |
| |
| Excludes1 |
congenital cutaneous mastocytosis (Q82.2)
histiocytic neoplasms of uncertain behavior (D47.Z9)
malignant mast cell neoplasm (C96.2-)
|
|
| |
 D47.01 |
|
Cutaneous mastocytosis |
| |
| Diffuse cutaneous mastocytosis | | Maculopapular cutaneous mastocytosis | | Solitary mastocytoma | | Telangiectasia macularis eruptiva perstans | | Urticaria pigmentosa |
| Excludes1 |
congenital (diffuse) (maculopapular) cutaneous mastocytosis (Q82.2)
congenital urticaria pigmentosa (Q82.2)
extracutaneous mastocytoma (D47.09)
|
|
| | |
| D47.02 |
|
Systemic mastocytosis |
| |
| Indolent systemic mastocytosis | | Isolated bone marrow mastocytosis | | Smoldering systemic mastocytosis | | Systemic mastocytosis, with an associated hematological non-mast cell lineage disease (SM-AHNMD) |
| CodeAlso |
, if applicable, any associated hematological non-mast cell lineage disease, such as:
acute myeloid leukemia (C92.6-, C92.A-)
chronic myelomonocytic leukemia (C93.1-)
essential thrombocytosis (D47.3)
hypereosinophilic syndrome (D72.1)
myelodysplastic syndrome (D46.9)
myeloproliferative syndrome (D47.1)
non-Hodgkin lymphoma (C82-C85)
plasma cell myeloma (C90.0-)
polycythemia vera (D45)
|
| Excludes1 |
aggressive systemic mastocytosis (C96.21)
mast cell leukemia (C94.3-)
|
|
| | |
| D47.09 |
|
Other mast cell neoplasms of uncertain behavior |
| |
| Extracutaneous mastocytoma | | Mast cell tumor NOS | | Mastocytoma NOS | | Mastocytosis NOS |
|
| |
| |
| D47.1 |
|
Chronic myeloproliferative disease |
| |
| Chronic neutrophilic leukemia | | Myeloproliferative disease, unspecified |
| Excludes1 |
atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-)
chronic myeloid leukemia BCR/ABL-positive (C92.1-)
myelofibrosis NOS (D75.81)
myelophthisic anemia (D61.82)
myelophthisis (D61.82)
secondary myelofibrosis NOS (D75.81)
|
|
|
| |
| D47.2 |
|
Monoclonal gammopathy |
| |
| Monoclonal gammopathy of undetermined significance [MGUS] |
|
|
| |
| D47.3 |
|
Essential (hemorrhagic) thrombocythemia |
| |
| Essential thrombocytosis | | Idiopathic hemorrhagic thrombocythemia | | Primary thrombocytosis |
| Excludes2 |
reactive thrombocytosis (D75.838)
secondary thrombocytosis (D75.838)
thrombocythemia NOS (D75.839)
thrombocytosis NOS (D75.839)
|
|
|
| |
| D47.4 |
|
Osteomyelofibrosis |
| |
| Chronic idiopathic myelofibrosis | | Myelofibrosis (idiopathic) (with myeloid metaplasia) | | Myelosclerosis (megakaryocytic) with myeloid metaplasia | | Secondary myelofibrosis in myeloproliferative disease |
| Excludes1 |
acute myelofibrosis (C94.4-)
|
|
|
| |
| D47.Z |
|
Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue |
| |
| D47.Z1 |
|
Post-transplant lymphoproliferative disorder (PTLD) |
| |
| CodeFirst |
complications of transplanted organs and tissue (T86.-)
|
| nonPrimary |
Yes
|
|
| | |
| D47.Z2 |
|
Castleman disease |
| |
| CodeAlso |
, if applicable, human herpesvirus 8 infection (B10.89)
|
| Excludes2 |
Kaposi's sarcoma (C46.-)
|
|
| | |
| D47.Z9 |
|
Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue |
| |
| Histiocytic tumors of uncertain behavior |
|
| |
| |
| D47.9 |
|
Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified |
| |
| Lymphoproliferative disease NOS |
|
|